Corcept Therapeutics (FRA:HTD) Common Stock : €0.1 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Corcept Therapeutics Common Stock?

Corcept Therapeutics's quarterly common stock declined from Sep. 2023 (€0.1 Mil) to Dec. 2023 (€0.1 Mil) but then stayed the same from Dec. 2023 (€0.1 Mil) to Mar. 2024 (€0.1 Mil).

Corcept Therapeutics's annual common stock increased from Dec. 2021 (€0.1 Mil) to Dec. 2022 (€0.1 Mil) but then declined from Dec. 2022 (€0.1 Mil) to Dec. 2023 (€0.1 Mil).

Corcept Therapeutics Common Stock Historical Data

The historical data trend for Corcept Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Common Stock Chart

Corcept Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.11

0.10

0.11

0.12

Corcept Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															0.12	0.12	0.13	0.12	0.12

Corcept Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Corcept Therapeutics (FRA:HTD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (FRA:HTD) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

CORT:USA

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.